Canavanine induces insulin release via activation of imidazoline I3 receptors

Clin Exp Pharmacol Physiol. 2015 Mar;42(3):263-8. doi: 10.1111/1440-1681.12348.

Abstract

The aim of the present study was to identify the effect of canavanine on the imidazoline receptor because canavanine is a guanidinium derivative that has a similar structure to imidazoline receptor ligands. Transfected Chinese hamster ovary-K1 cells expressing imidazoline receptors (nischarin (NISCH)-CHO-K1 cells) were used to elucidate the direct effects of canavanine on imidazoline receptors. In addition, the imidazoline I3 receptor has been implicated in stimulation of insulin secretion from pancreatic β-cells. Wistar rats were used to investigate the effects of canavanine (0.1, 1 and 2.5 mg/kg, i.v.) on insulin secretion. In addition the a specific I3 receptor antagonist KU14R (4 or 8 mg/kg, i.v.) was used to block I3 receptors. Canavanine decreased blood glucose by increasing plasma insulin in rats. In addition, canavanine increased calcium influx into NISCH-CHO-K1 cells in a manner similar to agmatine, the endogenous ligand of imidazoline receptors. Moreover, KU12R dose-dependently attenuated canavanine-induced insulin secretion in HIT-T15 pancreatic β-cells and in the plasma of rats. The data suggest that canavanine is an agonist of I3 receptors both in vivo and in vitro. Thus, canavanine would be a useful tool in imidazoline receptor research.

Keywords: Chinese hamster ovary-K1 cells; canavanine; imidazoline I3 receptor; insulin secretion; nischarin (NISCH).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • CHO Cells
  • Calcium / metabolism
  • Canavanine / pharmacology*
  • Cricetinae
  • Cricetulus
  • Imidazoline Receptors / metabolism*
  • Insulin / metabolism*
  • Insulin Secretion
  • Male
  • Rats
  • Rats, Wistar

Substances

  • Blood Glucose
  • Imidazoline Receptors
  • Insulin
  • Canavanine
  • Calcium